Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation

Author： Ekberg H.   Backman L.   Tufveson G.   Tyden G.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.31, Iss.1, 1999-02, pp. : 267-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of daclizumab (Zenapax) on prevention of acute rejection of renal transplantation

By Poorrezagholi F.   Einollahi B.   Firoozan A.   Nafar M.   Yadegari H.   Moghaddam S.M.M.H.   Simforoosh N.   Basiri A.   Farhangi S.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2735-2736

Elsevier

Access to resources Recommend Favorite

Acute Rejection Episodes Predict Long-Term Renal Transplantation Survival

By Kokado Y.   Takahara S.   Hatori M.   Ichimaru I.   Wang J.D.   Miki T.   Okuyama A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1537-1540

Elsevier

Access to resources Recommend Favorite

Neoral reduces the incidence of acute rejection after renal transplantation

By Sandrini S.   Setti G.   Gaggia P.   Chiappini R.   Maffeis R.   Tardanico R.   Maiorca R.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1758-1759

Elsevier

Access to resources Recommend Favorite

Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation

By Vincenti F.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2206-2207

Elsevier

Access to resources Recommend Favorite

Effect of acute rejection episodes on long-term renal graft survival

By Berczi C.   Asztalos L.   Kincses Z.   Locsey L.   Balazs G.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1775-1775

Elsevier

Access to resources Recommend Favorite